Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Heart Failure 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Social Determinants of Health 2Electrocardiography 2Echocardiography 2zanubrutinib 1sofosbuvir-velpatasvir drug combination 1acalabrutinib 1Vascular Stiffness 1Standard of Care 1Restraint, Physical 1Referral and Consultation 1Quality of Life 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutrition Assessment 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hematologic Tests 1Health Information Exchange 1Geritol 1Fish Oils 1Fatty Acids, Omega-3 1Ethanol 1Educational Status 1Early Intervention, Educational 1Diet, Mediterranean 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Vascular Stiffness × 1 year × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡